BMP6 and VDR gene polymorphisms are associated with osteonecrosis in a sickle cell anaemia cohort.
Gabriela S ArcanjoMariana B SouzaIgor F DomingosDiego Antonio Pereira-MartinsDiego A FalcãoJessica V BatistaBetania L HatzlhoferMadi V DinizAlexsandro P SilvaWerbson L GuaranáManuela F HazinAderson S AraujoAnderson Ferreira da CunhaSara Teresinha Olalla SaadFernando F CostaAntônio Roberto Lucena de AraujoMarcos André C BezerraPublished in: British journal of haematology (2024)
The occurrence and severity of osteonecrosis in sickle cell anaemia (SCA) vary due to risk factors, including genetic modifiers. Bone morphogenetic proteins (BMPs), particularly BMP6, and the vitamin D receptor (VDR) play key roles in cartilage and bone metabolism, making them potential contributors to orthopaedic outcomes in SCA. Here, we evaluated the association of polymorphisms in BMP6 (rs3812163, rs270393 and rs449853) and VDR (FokI rs2228570 and Cdx2 rs11568820) genes with osteonecrosis risk in a Brazilian SCA cohort. A total of 177 unrelated SCA patients were selected. The AA genotype of BMP6 rs3812163 was independently associated with a lower osteonecrosis risk (p = 0.015; odds ratio (OR): 0.38; 95% confidence interval (CI): 0.18-0.83) and with the long-term cumulative incidence of osteonecrosis (p = 0.029; hazard ratio: 0.56, 95% CI: 0.34-0.94). The VDR rs2228570 TT genotype was independently associated with a lower osteonecrosis risk (p = 0.039; OR: 0.14; 95% CI: 0.02-0.90). In summary, our results provide evidence that BMP6 rs3812163 and the VDR rs2228570 might be implicated in osteonecrosis pathophysiology in SCA and might help identify individuals at high risk.
Keyphrases
- mesenchymal stem cells
- risk factors
- bone regeneration
- end stage renal disease
- bone mineral density
- chronic kidney disease
- genome wide
- risk assessment
- metabolic syndrome
- type diabetes
- gene expression
- transcription factor
- postmenopausal women
- climate change
- bone loss
- patient reported
- breast cancer risk
- glycemic control